Volume 5, Supplement 5, 2003 | MedReviews

<script language="JavaScript1.1" src="https://ad.doubleclick.net/ddm/adj/N9515.3206767MEDREVIEWS0/B22310636.252721090;abr=!ie;sz=728x90;ord=1;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=?"> <![CDATA[// ><!]]> </script>

Urology

Volume 5, Supplement 5, 2003

Volume 5, Supplement 5, 2003

Table of Contents

Supplement

Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia

Herbert Lepor

Supplement

The Medical Therapy of Prostatic Symptoms Study: What Will We Learn?

Kevin M. Slawin

Supplement

A Primary Care Physician's Perspective on Benign Prostatic Hyperplasia

Louis Kuritzky

Supplement

Self-Assessment Post-Test

Herbert Lepor

Supplement

Herbert Lepor

Supplement

Clinical Evaluation of Benign Prostatic Hyperplasia

Kevin T. McVary

Supplement

5-Alpha-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia

Claus G. Roehrborn

Supplement

Long-Term Experience With 5-Alpha-Reductase Inhibitors

E. Darracott Vaughan